Huntleigh Healthcare Reports the US FDA’s 510(k) Clearance of Dawes-Redman CTG Analysis to Improve Non-Stress Test Interpretation in Fetuses

Shots:

• The US FDA has granted 510(k) clearance to the Dawes-Redman CTG analysis, improving non-stress test (NST) interpretation in fetuses to help prevent poor outcomes for babies & families
• Dawes-Redman CTG assesses NST traces against criteria of normality, using database of 100,000+ traces & their outcomes, by evaluating basal heart rate, sinusoidal rhythms, & short-term variation (STV) of the fetal heart rate, which cannot be calculated manually
• CTG Analysis was further enhanced by Oxford researchers, reducing trace analysis time from >30min. to 10min. for clinicians; Dawes-Redman CTG is available in Huntleigh’s Sonicaid TEAM3 series & the OBIX BeCA fetal monitor

Ref: Huntleigh  | Image: Huntleigh

Related News:- Avatar Medical & FX Shoulder Solutions Reports the US FDA’s 510(k) Clearance of brAIn Shoulder Positioning System (SPS) for Arthroscopic Surgeries

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com